Protective Medical Apparel Maker Medline Considering An IPO
Medline Considers IPO Amid Growing Demand for Personal Protective Equipment
Workers at Medline Industries assemble Personal Protection Equipment (PPE) kits to be shipped out to various health facilities at their warehouse in Mundelein, Illinois, U.S., on Monday, Oct. 20, 2014. The personal protection kits, which typically include a hooded body suit, face shield, boot covers, mask, gloves, Epi-clenz hand sanitizer and a biohazard bag, can be used for healthcare professionals that are treating patients with the Ebola virus. Photographer: Tim Boyle/Bloomberg
© 2014 Bloomberg Finance LP
Medline, a leading manufacturer of personal protective equipment (PPE), is exploring the possibility of going public through an initial public offering (IPO) later this year. With annual sales exceeding $23 billion, Medline has experienced significant growth, fueled by the demand for PPE during the COVID-19 pandemic.
The company, headquartered in Northfield, Illinois, has a global workforce of 43,000 employees and offers a wide range of healthcare products, including masks, surgical gowns, sanitizing solutions, and biohazard bags. Bloomberg News first reported on the potential IPO, which could raise approximately $5 billion for the company.
In 2021, Medline underwent a major ownership transition when private equity firms, including Blackstone, Carlyle, and Hellman & Friedman, acquired a majority stake valued at $30 billion. Despite this change, the Mills family, who founded the company in 1966, retained a 25% ownership stake.
Under the leadership of CEO Jim Boyle and President/COO Jim Pigott, who took over from the longstanding Mills family executives in a five-year succession plan, Medline continued to expand its market presence and revenue. The company’s revenue surpassed $21 billion in 2021, driven by new partnerships with healthcare providers and health systems seeking PPE supplies.
Founded over a century ago, Medline has a rich history of serving the healthcare industry with quality products. During the height of the pandemic, the company pivoted its production to meet the surging demand for essential items like face masks, disinfectants, and other protective gear. The dedication and innovation of the Medline team were evident as they worked tirelessly to meet the needs of frontline workers.
As Medline prepares for a potential IPO, it stands poised to further solidify its position as a key player in the global healthcare supply chain. With a strong reputation for quality and reliability, Medline continues to be a trusted partner for healthcare providers worldwide.
